Sunzen Biotech Berhad reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was MYR 25.98 million compared to MYR 23.89 million a year ago. Net income was MYR 1.69 million compared to MYR 0.951 million a year ago. Basic earnings per share was MYR 0.0024 compared to MYR 0.0014 a year ago. Diluted earnings per share was MYR 0.0023 compared to MYR 0.0013 a year ago.
For the nine months, sales was MYR 68.79 million compared to MYR 80.07 million a year ago. Net income was MYR 3.69 million compared to MYR 2.5 million a year ago. Basic earnings per share was MYR 0.0052 compared to MYR 0.0036 a year ago. Diluted earnings per share was MYR 0.0051 compared to MYR 0.0034 a year ago.